Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy

K K Tha1, S Terae, M Sugiura

  • 1Department of Radiology, Hokkaido University School of Medicine, Kita-ku, Sapporo, Japan. khinkhintha@yahoo.co.uk

Insights

5-fluorouracil (5-FU) chemotherapy can cause leukoencephalopathy, a reversible brain condition. Serial brain MRI with diffusion-weighted imaging (DWI) showed restricted diffusion that improved over time, aiding diagnosis.

Area of Science:

  • Neuroimaging
  • Neuroradiology
  • Oncology

Background:

  • 5-fluorouracil (5-FU) is a common chemotherapeutic agent.
  • Leukoencephalopathy is a potential adverse effect of 5-FU treatment.
  • Serial brain MRI, including diffusion-weighted imaging (DWI), is crucial for evaluating neurological complications.

Observation:

  • Initial MRI revealed diffuse white matter hyperintensity in T2-weighted and FLAIR sequences.
  • T1-weighted images showed non-enhanced hypointensity.
  • Diffusion-weighted imaging (DWI) demonstrated conspicuous hyperintensity with decreased apparent diffusion coefficient (ADC), indicating restricted diffusion.

Findings:

  • Serial MRI studies showed resolution of most abnormal signal intensities.
  • Decreased ADC values approached normal levels over time.
  • Some residual white matter hyperintensity persisted, but ADC values normalized.
  • Diffusion-weighted imaging (DWI) revealed directional dependence of diffusion and preservation of anisotropy.

Implications:

  • Early-stage 5-FU-induced leukoencephalopathy is characterized by reversible restricted diffusion.
  • Diffusion-weighted imaging (DWI) is a valuable tool for diagnosing 5-FU-induced leukoencephalopathy.
  • Preservation of anisotropy suggests the reversibility of white matter changes.

Related Concept Videos